Adherence to combination therapy enhances sustained response in genotype-1–infected patients with chronic hepatitis C
Top Cited Papers
- 1 October 2002
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 123 (4), 1061-1069
- https://doi.org/10.1053/gast.2002.35950
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialThe Lancet, 2001
- A Randomized, Double–Blind Trial Comparing Pegylated Interferon Alfa–2B to Interferon Alfa–2B As Initial Treatment for Chronic Hepatitis CHepatology, 2001
- Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV InfectionAnnals of Internal Medicine, 2000
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994New England Journal of Medicine, 1999
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CNew England Journal of Medicine, 1998
- Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virusThe Lancet, 1998
- 10-year follow-up after interferon-α therapy for chronic hepatitis CHepatology, 1998
- Correlation of serum HCV RNA and alanine aminotransferase levels in chronic hepatitis C patients during treatment with ribavirinJournal of Gastroenterology and Hepatology, 1994
- Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assayJournal of General Virology, 1993
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†Hepatology, 1981